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Part 1 – Generating transgenic animals via Sperm 
Mediated Gene Transfer 
Introduction: approaching the single step transgenesis 
Transgenesis 
A transgenic animal can be defined as one having any specific, targeted 
genetic modification (Dunn et al., 2005).  
Virtually every DNA sequence maybe expressed in transgenic animals, and 
the recombinant DNA techniques allow binding genic sequence to regulatory 
elements in order to consent exogenous gene expression in a way tissue-
specific or even ubiquitary. The exogenous DNA is then inherited by the 
offspring through the germ line. Literature data set the creation of the first 
transgenic mouse in 1980, by Gordon J.W. et al.; lately many other groups 
reached this goal, proving the efficiency of the transgenesis and the 
conservation in the following generations (Brinster et al., 1981; Constantini & 
Lacy, 1981; Wagner et al., 1981). 
The production of transgenic animals responds to different aims, in the 
Xenome project – on which I spent most of the work - the purpose is the 
engineering of the porcine genome for xenotransplantation studies in 
primates (Xenome integrated project, 2006). 
Sperm Mediated Gene Transfer 
In the past fifteen years the laboratory of professors Bacci ML and Forni M 
focused on a transgenesis technique: the SMGT. The main idea underlying 
this technique is the intrinsic ability of sperm cells to bind and internalise 
exogenous DNA and to transfer it into the oocyte at fertilisation (Bacci, 2007). 
 
The founding that sperms were able to bind to specific genic sequence and 
carry them into the oocyte is dated back to 1971 (Brackett et al., 1971). But 
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then there were no further works in that direction for about eighteen years, 
when the preliminary data found confirmation in sea-urchin (Arezzo, 1989) 
and in mouse (Lavitrano et al., 1989).  
Subsequently, SMGT was successfully adapted and optimised for use in large 
animals by a tight collaboration with DiMorFiPa research group (Sperandio et 
al., 1996). From then onwards more success was obtained: human decay 
accelerating factor (hDAF) transgenic pig lines had been produced with high 
efficiency (Lavitrano et al., 2002; 2003): those transgenic pigs showed good 
protection against a hyperacute rejection challenge in ex-vivo experiments 
(Smolenski et al., 2007).  
 
 
Figure 1: Sperm-mediated gene transfer in the pig. (Lavitrano et al., 2007) 
 
It has also been demonstrated that SMGT is also suitable for the 
transformation of the animal genome with a non viral episomal vector 
(Manzini et al., 2006). Other researchers have also proven the broad 
applicability of this technique to different animal species, from sea urchin to 
cattle (Wall, 2002), so SMGT can be considered as a powerful and potentially 
universal technique (Bacci, 2007). 
  
 
5 
5 Part 1 – Generating transgenic animals via Sperm Mediated Gene Transfer 
The exogenous DNA molecules bind to the sperm cell‘s head in the 
subacrosomal region and in the proximity of the equatorial area. Once bound 
to the cell membrane, DNA molecules are taken up (Francolini et al. 1993). 
The process of DNA binding and internalisation is not a random event. The 
exogenous DNA interacts with DNA-binding proteins (DBPs) of 30–35 kDa, 
which are present on the sperm cell surface (Lavitrano et al. 1992; Zani et al. 
1995) and it has been demonstrated that major histocompatibility complex 
(MHC) class II and CD4 molecules also play a role in the process of 
sperm/DNA interaction (Lavitrano et al. 1997b). In fact, sperm cells from 
MHC class II-knockout mice have a reduced ability to bind DNA compared 
with sperm cells from wild-type animals (Mori et al. 1990; Wu et al. 1990). 
Conversely, spermatozoa from CD4-knockout mice are fully capable of 
binding exogenous DNA, yet lose the ability to internalise it. To further 
support the role of CD4 in DNA transfer, it has been shown that nuclear 
internalisation of exogenous DNA is prevented in wild-type sperm cells pre-
incubated with anti-CD4 monoclonal antibodies (mAbs). Thus, although not 
present in mature sperm cells, MHC class II expression appears to be required 
during spermatogenesis to produce sperm cells capable of taking up foreign 
DNA, whereas CD4 molecules present on sperm cells mediate the nuclear 
internalisation of sperm-bound DNA (Lavitrano et al. 1997b). 
The SMGT molecular model hasn‘t been in the spotlight for while, and then 
recently Wang et al. (2011) described a correspondence between CD4 
polymorphisms and ability of sperm to internalize exogenous DNA. This 
reinforces the previous finding and anticipates CD4 as target for future and 
definitive studies on the SMGT model. 
 
Nevertheless mature spermatozoa are naturally protected against the 
intrusion of foreign DNA molecules; in fact, it has been identified a factor 
(inhibitory factor 1, IF-1) present in the seminal fluid of mammals that blocks 
the binding of exogenous DNA to sperm cells. This factor also exerted a 
powerful inhibitory effect on DNA uptake in sperm cells of heterologous 
species. The DNA Binding Proteins (DBPs) appeared to be the specific target 
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through which the inhibition is mediated because, in the presence of the 
inhibitory factor, the DBPs lose their ability to bind exogenous DNA (Zani et 
al. 1995). Thus, the interaction of exogenous DNA with sperm cells does not 
appear to be a casual event but, in contrast, relies on a molecular mechanism 
based on the cooperation of specific protein factors. In the absence of IF-1, 
DBPs are able to interact with DNA and the complex can translocate the DNA 
into the cell in a CD4-dependent manner (Lavitrano et al. 1997b). Thus, it is of 
utmost importance that seminal fluid is removed from sperm samples by 
extensive washing as soon as possible after ejaculation. 
 
 
Figure 2: Schematic representation of the process of internalization of foreign DNA in 
the sperm nucleus (Spadafora et al., 1998). 
 
The attention on the seminal plasma complete removal has always been a 
crucial part of SMGT experiments as shown in the recent publications by Zhao 
et al. on goat spermatozoa (Zhao et al., 2011), Collares et al. in chickens 
(Collares et al., 2011), and particularly in catfish (Rhamdia quelen) 
spermatozoa, where Campos et al. observed a strong DNase activity in 
seminal plasma (Campos et al., 2011). 
  
 
7 
7 Part 1 – Generating transgenic animals via Sperm Mediated Gene Transfer 
Even though much effort has been spent on studying the relationship between 
SMGT and seminal plasma, the Interfering Factor I is yet to be uniquely 
identified. 
After DNA–sperm cell interaction and internalisation, the subsequent step 
involves integration of the exogenous DNA into the genome. 
 
It is not known whether the DNA integration event happens before 
fertilisation. Interestingly, using the SMGT technique, it has been found that 
foreign DNA sequences are tightly bound to the sperm nuclear scaffold and 
that integration of the exogenous DNA occurs preferentially in the long 
interspersed nuclear element type-1 elements, repeated sequences 
interspersed into the genome. Moreover the presence of a topoisomerase II 
consensus sequence at one end of the integration site suggests a possible role 
for this enzyme in the integration process (Spadafora et al., 1998). 
 
These considerations characterize the SMGT as a very interesting technique 
that still requires deep molecular characterization but at the same time, 
guarantees results in the production of transgenic animals. In a consistent 
part of my work we focused on the developing of new methodologies for 
SMGT, particularly in swine, and their application in the in vivo and in vitro 
production of transgenic animals within the Xenome Project. 
 
Reproductive biotechnologies 
Several systems have been established to generate embryos in vitro, however 
the efficiency is still low. The major problems include improper oocyte 
maturation, both nucleus and cytoplasmic, and polyspermy. The importance 
of the development and identification of defined in vitro conditions for oocyte 
maturation and fertilization should not be underestimate, since most 
reproductive technologies rely on these basic techniques  (Sun & Nagai, 
2003). 
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In Vitro Maturation 
Maturation of the oocytes includes two aspects: nuclear maturation and 
cytoplasmic maturation. Generally an oocyte is regarded to be matured when 
the first polar body is extruded (nuclear maturation) and the oocyte is 
arrested at the MII stage.  
Although nuclear matured oocytes can be fertilized, they may be 
developmentally incompetent due to the deficiency in some cytoplasmic 
maturation. Thus, the developmental potential requires synchronous nuclear 
maturation and cytoplasmic maturation (Sun & Nagai, 2003). 
In Vitro Maturation (IVM) protocols have the aim to recreate artificially the 
most favorable conditions to allow cytoplasmatic and nuclear maturation of 
the oocyte. 
In swines, IVM applied to female gametes is based on two phases, for a total 
duration of  about 44-48 hours. 
The first phase is 24 hours long, and is characterized by the presence of 
dibutyrril-cAMP, eCG and hCG: the whole medium is called IVM maturation 
medium type B. 
The db-cAMP is a synthesis analogue of cAMP added to culture medium; it is 
a tiny molecule able to penetrate cell and nuclear membranes, when it reaches 
the nucleus keeps the meiotic process blocked untill it is removed by nuclear 
exposition to hCG gonadotropin, that recreates LH pre-ovulatory peak. 
hCG and eCG are both corionic gonadotropin, respectively derivating from 
―human‖ and  ―equine‖. Their action is very important, because they act like 
gonadotropy hormones FSH (Follicule Stimulating Hormone) and LH 
(Luteinizing Hormone) inside an organism. 
eCG is FSH-like: its target are the follicular somatic cells of Teca and 
Granulosa, and promotes the development of cumulus structures deputated to 
protect and feed the egg cell. During the first phase of IVM process, this 
hormone maintains working the gap-junction between somatic cells and 
oocyte, promoting the circulation of nutritive substances to oocyte. 
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hCG is LH-like: its presence allows the meiosys restart when db-cAMP levels 
decrease. 
These molecules allow the cell to adapt to the new environment and to 
prepare to next steps in maturation. 
The second maturation phase is 24 hours long, and takes place in the same 
medium, IVM maturation medium, but without db-cAMP and hormones 
neither. This is the so called IVM maturation medium type A. 
Meiotic maturation is fully reached at the end of this phase, gap-junction 
broke up and somatic cells start jaluronic acid production, in order to expand 
more and more the cumulus. These transformation are index of the 
maturation. 
At the end of the two phases swine oocyte should have concluded both 
maturation, cytoplasmatic and nuclear. 
 
In Vitro Fertilization 
In Vitro Fertilization (IVF) allows the fertilization event in a in vitro system. 
Fertilization requires mature oocytes: both cytoplasm and nucleus (at MII 
stadium). To evaluate cytoplasmatic maturation before fertilization is quite 
complex: it is possible only in a second time, based on effects subsequent to 
fertilization event. One of the most important parameters is the ability of a 
mature oocyte to prevent polyspermy and to protect normospermy. It is such 
a critical step because polyspermy in swine is quite common. 
Besides, oocytes must be able to de-condense sperm head, in order to create 
male pronucleus, essential for singamy. 
 
Sperm Sorting 
It is estimated that as many as 60,000 offspring, mostly cattle, have been 
produced in the past 10 years using AI or some other means of transport with 
spermatozoa sexed by flow cytometric sperm sorting and DNA as the marker 
of differentiation.  
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Numerous works demonstrated that the only reliable marker for the efficient 
separation of X- and Y-chromosome bearing spermatozoa is DNA (Johnson et 
al, 2005). This method is now used worldwide and was known from the 
beginning as the Beltsville Sperm Sexing Technology. A fluorescent dye 
(Hoechst 33342) is used to stain DNA and the method is based on the 
separation of sperm using flow cytometric sorting to sort fluorescently labeled 
sperm based on their relative content of DNA within each population of X- 
and Y-spermatozoa. The technology is being applied in livestock, laboratory 
animals, and zoo animals, even in humans, with a success rate of 90-95% in 
shifting the sex ratio of offspring. Delivery of sexed sperm to the site of 
fertilization varies with species. Although sperm of all species can be sorted 
with high purity, achieving pregnancies with the low numbers of sperm 
needed for commercial application remains particularly elusive in swine.  
With these premises it is of crucial interest to couple a transgenesis method as 
SMGT with sperm sorting: the potential applications in the field of animal 
productions are large. With an offspring of defined sex it would be much 
easier to undercut the costs of production of transgenic, maximizing the 
number of transgene-carrying animals and at the same time being able to 
mate all the subjects. 
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Appendix 1 – Spermatozoa and DNA 
Assessing quality parameters in semen 
 
The first part of the work focused on the assessment of optimal quality 
parameters during the SMGT treatment: the aim of the study was to 
investigate the influence of SMGT treatment and exogenous DNA uptake on 
sperm quality. 
In our publication we demonstrated that SMGT-treated spermatozoa retain 
good quality and fertilization for at least twenty four hours. 
 
Article: 
Sperm-mediated gene transfer-treated 
spermatozoa maintain good quality parameters 
and in vitro fertilization ability in swine. 
Bacci ML, Zannoni A, De Cecco M, Fantinati P, Bernardini C, Galeati G, 
Spinaci M, Giovannoni R, Lavitrano M, Seren E, Forni M. 
Theriogenology. 2009 Dec;72(9):1163-70. Epub 2009 Sep 19. 
PMID: 19767086 
URL: http://www.ncbi.nlm.nih.gov/pubmed/19767086 
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Development of a method for screening DNA uptake in sperm 
 
In order to consolidate the use of SMGT in transgenesis with multiple 
exogenous constructs, we developed a method that allows a real time 
screening of DNA uptake. This work can be considered as a breakthrough 
since the previous standard approach was a radiolabeled 3H-DNA 
coincubation, that prevent the screening of more than one construct.  
Our work, published on the Journal of Biomolecular Techniques, relies on 
fluorescent-specific peaks for each construct, and their diminution due to 
internalization during the sperm – DNA coincubation phase. This is 
particularly interesting for experiments, like our Xenome project, where more 
than one type of plasmid is involved and they are all required for a successful 
transgenesis. 
 
Article: 
A method for uptake quantification of multiple 
fluorescent DNAs in boar semen as an alternative 
to radiolabeling. 
De Cecco M, Zannoni A, Bernardini C, Lavitrano M, Bacci ML, Forni M. 
J Biomol Tech. 2010 Jul;21(2):61-5. 
PMID: 20592868 
URL: http://www.ncbi.nlm.nih.gov/pubmed/20592868 
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Appendix 2 – Production and genotyping of porcine 
blastocysts 
Use of SMGT to generate multiple transgenic embryos 
 
The expertise gained in the previous work was exploited in the production of 
1-step genetically modified embryos. The three constructs carried genes 
involved in the modulation of inflammatory processes (hHO1, hCD39, and 
hCD73).  
The results, published on Transplant Proc, suggest that this system allowed an 
effective preliminary test of transgenesis, majorly reducing the number of 
animals used in the experiments and fulfilling important ethical issues. 
 
Article: 
In Vitro Production of Multigene Transgenic 
Blastocysts via Sperm-Mediated Gene Transfer 
Allows Rapid Screening of Constructs to Be Used 
in Xenotransplantation Experiments. 
Vargiolu A, Manzini S, De Cecco M, Bacci ML, Forni M, Galeati G, Cerrito 
MG, Busnelli M, Lavitrano M, Giovannoni R. 
Transplant Proc. 2010 Jul-Aug;42(6):2142-5. 
PMID: 20692428 
URL: http://www.ncbi.nlm.nih.gov/pubmed/20692428 
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Appendix 3 – Production of transgenic blastocysts of 
predetermined sex 
Use of sperm sorting techniques and SMGT to generate transgenic 
embryos 
 
The final part of the work on sperm mediated gene transfer focused on 
proving the possibility to positively couple sperm sexing with SMGT, in order 
to speed up the assessment of homozygous lines of transgenic pigs. 
After much work in the tuning of the protocol, the method we developed and 
published on Theriogenology allows to produce transgenic swine blastocysts 
of pre-determined gender. 
 
Article: 
Coupling sperm mediated gene transfer and 
sperm sorting techniques: a new perspective for 
swine transgenesis. 
De Cecco M, Spinaci M, Zannoni A, Bernardini C, Seren E, Forni M, Bacci 
ML.  
Theriogenology. 2010 Sep 15;74(5):856-62. Epub 2010 May 26. 
PMID: 20537690 
URL: http://www.ncbi.nlm.nih.gov/pubmed/20537690 
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Part 2 – Silencing myc through RNA interference 
Introduction 
Inhibition of protein synthesis extends lifespan in invertebrates and 
mammals. Lifespan extension has been obtained by knocking-down genes 
encoding ribosomal proteins or controlling translation initiation, by inhibiting 
the TOR pathway‘s activity, and by inhibiting ribosomal biogenesis through 
the use of drugs. 
The TOR pathway is a central pathway in nutrient sensing conserved from 
yeast to humans (Evans et al., 2010), (Stanfel et al., 2009), (Wullschleger et 
al., 2006)  it responds to amino-acid availability and to changes in the 
ATP/AMP ratio. Nutrient sensing in multicellular organisms is conveyed 
through the insulin/IGF pathway by the hormonal action of insulin. The 
insulin/IGF pathway triggers a cascade of phosphorylation events and, 
through the action of the PI3K and Akt kinases, activates the pathway branch 
containing the TOR complex 1 (TORC1). In the presence of an abundance of 
nutrients, TORC1 coordinates protein synthesis by promoting both ribosomal 
biogenesis and by regulating translation initiation via genes such as S6k and 
4E-BP.  
When nutritional resources are low or the animal is subject to stresses such as 
hypoxia or DNA damage, TOR activity is repressed to inhibit cell growth and 
proliferation. Consistently, inhibition of TOR activity has been observed in 
Dietary Restriction (DR) animals (Stanfel et al., 2009). In particular, epistatic 
studies in invertebrates are consistent with the hypothesis that TOR mediates 
at least part of the longevity response of DR (Hansen et al., 2007), (Kaeberlein 
et al., 2005), (Kapahi et al., 2004), (Hansen et al., 2008). In mammals, a 
recent study on DR mice has reported a significant increase in the expression 
of DNA-damage inducible transcript 4 (Ddit4), a key inhibitor of the TOR 
pathway, and a reduction in 4E-BP1 phosphorylation (Estep et al., 2009). 
Phosphorylated 4E-BP1 releases eIF4E, which is then free to associate with 
eIF4G to stimulate translation initiation (Wullschleger et al., 2006).  
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Interestingly, Zid et al (2009) show that: the d4E-BP protein, the sole fly 4E-
BP ortholog, is upregulated in DR fruit flies; 4E-BP is required for maximal 
lifespan extension upon DR in Drosophila; and overexpression of activated 
d4E-BP extends lifespan. However, life span extension was abrogated in the 
activated 4E-BP alleles upon DR, consistent with a model in which DR 
increases levels of 4E-BP but at the same time, reduces 4E-BP 
phosphorylation. 
Direct inhibition of TOR signaling has been shown to extend life span in yeast 
(Kaeberlein et al., 2005), worms (Vellai et al., 2003), and flies (Kapahi et al., 
2004). Recently, several studies have shown that TOR activity modulates 
mammalian aging as well. Harrison et al. report that when genetically 
heterogeneous mice are fed the TOR inhibitor rapamycin, they live 
significantly longer than mice on a normal diet (28% for males and 38% for 
females increased life expectancy from time of treatment) (Harrison et al., 
2009). Notably, these results were obtained by starting the rapamycin 
treatment at a relatively old age (20 months old mice, roughly equivalent to 
60 years old humans), and similar results were obtained independently in 
three independent groups of mice at three research sites. Chen et al. describe 
a significant increase in mouse life span when rapamycin is fed to 22-24 
month old mice, and report a protective effect from experimental infection 
with influenza virus when rapamycin is administered in a 6 week bout to even 
older mice (26 month) (Chen et al., 2009). In addition, life span extension 
and resistance to age-related pathologies has also been achieved in mice by 
directly targeting components of the TOR pathway, specifically by deleting the 
ribosomal S6 protein kinase 1 (S6K1) (Selman et al., 2009). The same study 
showed that S6K1 deletion induced expression patterns similar to those 
observed in DR. 
Increased life span can also be achieved by modulating the expression of 
genes downstream of the TOR pathway such as genes involved in ribosomal 
biogenesis and translation initiation factors. For example, Steffen et al 
showed that deletion of genes encoding proteins within the 60S subunit or its 
processing factors extend lifespan in Saccaromyces cerevisiae, and that an 
analogous effect can be achieved by using a small molecule that inhibits the 
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60S subunit biogenesis (Steffen et al., 2008). In Caenorhabditis elegans life 
span extension has been achieved by inhibiting the gene encoding for ifg-1, 
the worm homologue of translation initiation factor eIF4G, which is a scaffold 
protein in the cap-binding complex (Pan et al., 2007). 
Myc and protein synthesis 
Myc encodes a transcriptional regulator whose inappropriate expression is 
correlated with a wide array of cancers (Dang et al., 2006), (Grandori et al., 
2000), (Meyer et al., 2008). At the cellular level Myc activity has been linked 
with cell division, accumulation of mass, differentiation, and programmed cell 
death. 
In the recent years Myc‘s central role in the regulation of protein synthesis has 
emerged (van Riggelen et al., 2010). Myc has been shown to regulate protein 
synthesis at multiple levels by controlling the transcription of ribosomal RNA 
and proteins, genes involved in processing of ribosomal RNA, genes involved 
in the nuclear export of ribosomal subunits, and translation initiation factors. 
The Myc:Max:Mxd transcriptional network controls the transcription of a 
large fraction of the genome (at least 15%). Myc and Max form a heterodimer 
that recognizes and binds to E-box sequences found in the promoters and 
5'UTRs of many genes. This binding recruits co-regulatory factors leading to 
the acetylation of nucleosomal histones and expression of the target gene. 
Max can form a heterodimer with members of the Mxd family, and such 
dimer can recognize and bind to E-boxes, and antagonize the Myc-Max 
complex activity. The Myc-Max heterodimer can also bind to the transcription 
factor MIZ1 and act as a transrepressor of MIZ1 targets. Finally, Myc can form 
a complex with an RNA polymerase III-specific transcription factor (TFIIIB) 
and stimulate the transcription of transfer RNA (tRNA) and 5S ribosomal 
RNA genes. 
The Myc:Max:Mxd network in Drosophila has the advantage that it contains 
one member for each class: Myc, Max and Mnt. Hence it has a much simpler 
form than in higher organisms where each class can contain multiple 
homologs. 
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Teleman et al. have recently demonstrated that a link exists between the TOR 
pathway and Myc (Teleman et al., 2008). Specifically they showed that in D. 
melanogaster TORC1 appears to regulate Myc primarily at the post-
transcriptional level, and that, in vivo, Myc acts as a mediator of nutrient-
regulated gene expression downstream of TOR. Because the vast majority of 
these genes are involved in ribosome assembly, they propose a model in which 
Myc mediates TOR‘s regulation on ribosomal biogenesis. 
Professor Neretti together with the Stephen Helfand‘s lab then performed a 
statistical analysis using a linear model to detect which genes 1) were 
significantly different between HC and LC and 2) switched from the HC level 
to the LC level as a consequence of the switch in diet. Using a False Discovery 
Rate (FDR) (Storey et al., 2003) of 10%, we detected 387 switching genes, 
which we then used to perform a pathway analysis to detect what functional 
categories were significantly enriched among them. For this purpose, we ran 
the list of genes on the FlyMine website which performs an enrichment 
analysis using several collections of biological pathways in Drosophila from 
multiple databases (Lyne et al., 2007). The top 14 functional pathways in the 
enrichment analysis of the KEGG and Reactome databases were related to 
translation, apart from a single one, which was related to insulin synthesis 
and secretion. Of the 387 genes identified, 63 were part of the ―translation‖ 
gene ontology (GO:0006412) (Table 1), which was significantly enriched 
(hypergeometric test, p<2x10-17 after correction for multiple testing). As 
Table 1 shows, the list contains a large number of ribosomal proteins, whose 
expression is repressed after the switch and in DR flies. 
 
Table 1 - Switch Genes in the "translation" Gene Ontology 
Aats-asn eIF-3p66 mRpL39 RpL18 RpL31 RpL40 RpLP1 RpS18 RpS3A 
Aats-tyr eIF4AIII Qm RpL18A RpL32 RpL5 RpLP2 RpS19a RpS4 
Aats-val eIF-4B RpL10Ab RpL19 RpL34b RpL6 RpS11 RpS23 RpS5a 
CG33158 eIF-5A RpL11 RpL23 RpL35 RpL7 RpS13 RpS25 RpS8 
CG4699 eIF6 RpL14 RpL23A RpL35A RpL7A RpS15 RpS28b RpS9 
CG7414 mRpL3 RpL15 RpL26 RpL36 RpL8 RpS16 RpS29 Sta 
Ef2b mRpL38 RpL17 RpL27A RpL37A RpL9 RpS17 RpS30 Su(var)3-9 
  
 
31 
31 Part 2 – Silencing myc through RNA interference 
The Helfand lab performed several diet switch experiments and found a 
focused group of genes related to translation. Because of the well established 
role of protein synthesis in aging and the recent results linking Myc activity to 
ribosomal biogenesis they hypothesized that the Myc:Max:Mnt network 
activity could modulate lifespan. To test this, they decreased and increased 
Myc activity. A decreased activity can be achieved by either reducing Myc 
expression or by overexpressing its antagonist Mnt. According to literature, 
both interventions should lead to an increase in ribosomal biogenesis and 
translational activity. The opposite effect, that is a decrease in translational 
activity, can be achieved by reducing Myc expression.  
 
One of the most informative experimental strategies to determine the function 
of a protein is to remove it from a biological system in which it normally 
functions and study the resulting effects. 
Historically, loss-of-function analysis has been the domain of mutational 
genetics in model organisms. Over the past few years, however, double-
stranded RNA-induced gene silencing (RNAi) has emerged as a powerful tool 
for the functional characterization of proteins at the cellular level. In essence, 
RNAi blocks production of a specific protein and induces loss-of-function 
phenotypes as protein levels drop due to protein turnover and serial dilution 
by cell division (Fire et al., 1998), (Elbashir et al., 2001). Cultured Drosophila 
cell lines have become well-known experimental systems to use in 
combination with RNAi for both biological and technical reasons. Many 
different fly cell lines that were derived from various tissues or developmental 
stages are available from the Drosophila Genome Resource Center in 
Bloomington, IN (https://dgrc.cgb.indiana.edu/). Although some of the 
available lines are uncharacterized, many of them (e.g., S2, S2R+, cl-8, Kc167) 
are highly susceptible to RNAi after treatment with large double-stranded 
RNAs (dsRNAs). This is an advantage fly cells have over mammalian cells: use 
of longer dsRNAs eliminates the cost associated with siRNA synthesis 
necessary for mammalian cells and circumvents the difficulties associated 
with siRNA design. In addition, the Drosophila genome exhibits less 
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functional redundancy compared with mammalian systems, which makes it 
easier to produce a loss-of-function phenotype by inhibiting a single gene at a 
time. Finally, with the development of commercially available dsRNA libraries 
and screening facilities, fly cell lines have been used very effectively as gene 
discovery tools for a variety of cellular processes (Echeverri et al., 2006). 
The most widely used Drosophila cell line is named S2. S2 cells were 
originally derived from late embryonic stage Drosophila embryos as a 
spontaneously immortalized, nonclonal cell line (Schneider et al., 1972). 
These cells exhibit mesodermal characteristics and their repertoire of cellular 
behaviors and gene expression suggest that they are derived from 
hemocytes—professional macrophages that, in the fly, are responsible for 
phagocytosis of invading bacteria and apoptotic cells (Ramet et al., 2002). 
Morphologically, S2 cells come in at least two different varieties. The parent 
S2 cell line is roughly spherical, 15–20 mm in diameter, and adheres rather 
weakly to most tissue culture substrates. A second sub-line of S2 cells, 
designated S2R+, was isolated based on its ability to respond to application of 
soluble wingless protein and was conferred with the ‗R+‘ designation to reflect 
its different complement of membrane receptors. S2 and S2R+ cells divide 
rapidly, with about a 20-h cell cycle at room temperature (20–25 °C), and do 
not require specialized equipment for their culture apart from a sterile hood 
for passage. Thus, use of this cell line has many advantages to use as a model 
to study basic cellular function.  
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Aim 
The area of interest of this project is to study in detail the sub-pathway which 
includes Myc‘s control of protein synthesis via regulation of ribosomal 
biogenesis and translation initiation factors, and its effect on longevity. 
 
Therefore, in particular the aim is to develop and validate an optimal model in 
vivo and in vitro for Myc inhibition. The goal of this aim is to identify a 
translational and a transcriptional signature for lifespan extension via Myc 
through the protein synthesis pathway. The set of genes comprising these 
signatures will tell us which and how specific pathways are affected by Myc-
induced inhibition of protein synthesis, and will help us understand how these 
changes can have a lifespan extending effect. 
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Material and methods 
Cell culture 
We obtained Drosophila melanogaster Schneider 2 (S2) cells from the 
Drosophila Genomics Resource Center (DGRC) and used standard protocols 
for both cell culture and RNA interference (RNAi) as described previously by 
Rogers SL and Rogers GC (2008).  
The S2 cell line is derived from late embryonic stage Drosophila embryos as 
spontaneously immortalized, nonclonal cell line (Schneider et al., 1972). The 
optimal culture condition in a incubator is 25°C with atmospheric CO2 and O2 
concentration. 
The growth medium, Sf-900 II SFM (Invitrogen, cat. No. 10902), was brought 
to room temperature and then 1 ml of medium was dispensed per well in a 6-
well plate (Costar). Next, frozen cells were thawed by immersing the vial in a 
37°C water bath for less than a minute, then the cell suspension (1.2 ml) was 
transferred in the wells (200 µl each) using a sterile pipette in a cell culture 
hood. Cells were allowed to attach the bottom of the plate for 1h then the 
medium was gently removed and replaced with an equal volume of Sf-900 II 
SFM in order to avoid prolonged exposure to DMSO (present in the long-term 
storage frozen vials). To recover from thawing cells need 5-6 days of growth at 
25°C: then they should be in optimal condition to start passaging.  
Starting from the early passages, cells were split every 3-4 days at a constant 
ratio of 1:5. 
 
RNAi target genes  
Five genes were knocked down through RNAi; the information about the 
chosen genes are found on FlyMine (www.flymine.org) and in numerous 
papers (Teleman et al., 2008). 
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Gene qm D. melanogaster 
NCBI Gene Number 38816 
Name quemao 
Pathways Metabolic – Terpenoid backbone biosynthesis 
Length 5308 
 
Figure 3: Qm mapped interactions, both genetic (blue) and physics (red) 
 
Gene RpLp0 D. melanogaster 
NCBI Gene Number 40451 
Name Ribosomal protein LP0 
Pathways 
Ribosome – Eukaryotic Translation 
Termination – 3’ UTR mediated translational 
regulation 
Length 1446 
 
Figure 4: RpLp0 mapped interactions, both genetic (blue) and physics (red) 
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Gene RpLp2 D. melanogaster 
NCBI Gene Number 36855 
Name Ribosomal protein LP2 
Pathways 
Ribosome – Eukaryotic Translation 
Termination – 3’ UTR mediated translational 
regulation 
Length 639 
 
Figure 5: RpLp2 mapped interactions, no genetic interactions are visible (blue), only 
physics (red) 
  
  
 
37 
37 Part 2 – Silencing myc through RNA interference 
Gene dm D. melanogaster 
NCBI Gene Number 31310 
Name Diminutive 
Pathways Cell cycle, Mitotic 
Length 12834 
 
 
Figure 6: dm (myc) mapped interactions, both genetic (blue) and physics (red) 
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Gene RpS3 D. melanogaster 
NCBI Gene Number 42761 
Name Ribosomal Protein S3 
Pathways 
Ribosome - Eukaryotic Translation 
Termination – 3’ UTR mediated translational 
regulation 
Length 12834 
 
Figure 7: RpS3 mapped interactions, both genetic (blue) and physics (red) 
 
As suggested by Rogers et al., a positive control for RNAi was included in all 
the steps of cell culture. The Rho1 gene was picked because its efficient 
inhibition prevents the cells from completing cytokinesis, so the diameter 
increases two-three times.  
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Gene Rho1 D. melanogaster 
NCBI Gene Number 36775 
Name Rho1 
Pathways Several but in this case, focus on cytokinesis 
Length 12834 
 
dsRNA production 
Genomic DNA was used to amplify via PCR the target genes. Each primer 
contained the sequence of T7 promoter as described previously by Rogers et 
al. 
For all the target genes two regions were selected to be part of the 
experiments, with the exception of RpLp2 that has only one: as a matter of 
fact according to literature that is the only possible target for an effective 
interference experiment. 
 
ID R primer w/ T7 S primer w/ T7 
dm  
(pair 1) 
TAATACGACTCACTATAGG  
AGAGATCCGCAACATCGACT 
TAATACGACTCACTATAGG  
CGCTTCTGACAGACCGTGTA 
dm  
(pair 2) 
TAATACGACTCACTATAGG  
CTACCCACAAATCCCTCGTG 
TAATACGACTCACTATAGG  
TCTGATACGGTGTGCTCGAC 
   
RpS3 
(pair 1) 
TAATACGACTCACTATAGG  
GTTTCAACTTCGAGACCGGA 
TAATACGACTCACTATAGG  
ACGAATTTCATCGACTTGGC 
RpS3  
(pair 2) 
TAATACGACTCACTATAGG  
AGGTCATGTTGCCCTACGAC 
TAATACGACTCACTATAGG  
TCAGCTAGTCGCTCATTGGA 
   
RpLP0 
(pair 1) 
TAATACGACTCACTATAGG  
CGATGAGTTCCCAAAGTGCT 
TAATACGACTCACTATAGG  
TGTTCCCTTGGAAATTTTGG 
RpLP0 
(pair 2) 
TAATACGACTCACTATAGG  
AACATCTCGCCCTTCTCGTA 
TAATACGACTCACTATAGG  
TTCTTGAATCCGTTGGCAAT 
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RpLP2 
(pair 1) 
TAATACGACTCACTATAGG  
AATAAGCGGTTGAATGTGGC 
TAATACGACTCACTATAGG  
AAATGGTGAACGGATGGGT 
   
Qm 
(pair 1) 
TAATACGACTCACTATAGG  
TGCAAAAATAAGCCGTACCC 
TAATACGACTCACTATAGG  
CGCATTCTGATGTGGAACTG 
Qm 
(pair 2) 
TAATACGACTCACTATAGG  
CTTCAAACTGGAATGCGAGG 
TAATACGACTCACTATAGG  
TTTTGACGTCCAGGGAACTT 
 
Primers were resuspended in TE pH 8.0, in a stock concentration of 100 µM. 
Working aliquots for each primer pair consisted of a 1:10 dilution in water. 
End-point PCR were then setup according to Taq Platinum (Invitrogen) 
suggested protocol: 
DNA template for dsRNA 
production 
 
Buffer 10X 5 µl 
MgCl2 3 µl 
dNTPs (2.5 mM each) 5 µl 
T7 containing primers 1 µl 
DNA (50 ng) 1 µl 
Taq Platinum 0.5 µl 
sterile, deionized water 34.5 µl 
 
An aliquot of the PCR products was run on a 1.5% agarose gel in TAE 1X for 
60 minutes at 80 V constant. The remaining part of the PCR was purified with 
Qiaquick PCR Purification Kit (Qiagen), eluted in 35 µl H2O and quantified 
with Nano-Drop spectrophotometer. 
The T7 RNA polymerase promoter was used in the synthesis of dsRNA 
molecules with the T7 RiboMAX™ Express RNAi System (Promega). 
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T7 reaction components  
RiboMAX 2x buffer 20 µl 
DNA (~ 1 µg) + Water  16µl 
Enzyme mix 4 µl 
 
Transcription reactions were incubated at 37°C overnight: the following day 
the dsRNA were made according to the manufacturer‘s protocol, briefly: 
 Anneal the RNA strands by incubating at 70°C for 10 minutes, then 
slowly cool to room temperature in a thermocycler (~20 minutes): this 
allows annealing of the double stranded RNA 
 Dilute the RNase Solution (supplied with the kit) 1:200 in Nuclease-
Free Water 
 Add 2 µl of the freshly diluted solution and 2 µl of RNase-Free DNase 
(supplied with the kit) to the reaction. 
 Incubate for 30 minutes at 37°C: this removes template DNA and any 
remaining single-stranded RNA 
 Add 4 µl of 3M of Sodium Acetate (pH 5.2) and 40 µl of isopropanol, 
mix well and incubate 5 minutes on ice. 
 Spin a microcentrifuge at 13,400 rpm for 10 minutes 
 Wash the pellet with 500 µl ice-cold 70% Ethanol 
 Resuspend dsRNA pellets with 100 µl Nuclease-Free Water, quantify 
with Nano-Drop spectrophotometer and run a 1 µl aliquot on a 1.5% 
agarose gel in TAE 1x 
 Split into aliquots in order to avoid freeze-thaw cycles and store at -
80°C 
 
RNAi treatment on S2 cells 
The use of S2 cells for RNAi experiments was performed following the 
previously described procedure by Rogers et al. (Rogers et al., 2003), briefly: 
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 Plate the cells one day in advance, in order to start with a ~50% 
confluency 
 For each RNAi treatment, pipette 1 ml of Sf-900 II SFM medium into 
a 1.5 ml tube and dilute the dsRNA into the medium to a concentration 
of 10 µg/ml 
 Carefully remove the medium from cells (loosely attached to the 
bottom of the plate)  
 Replace it with dsRNA-containing medium 
 Repeat daily for 6 more days 
 
Total RNA and protein extraction 
Total RNA extraction from S2 cells was performed according to Trizol 
Reagent ® (Ambion) manual. Briefly: 
 Harvest cells by centrifugation and remove the media: no washing 
steps were included, as suggested by the product manual, in order to 
avoid the chances of mRNA degradation 
 Add 750 µl of TRIzol® Reagent per 250 µl of sample (generally ~10 x 
106 cells) 
 Lyse the cells in sample by pipetting up and down several times 
 Incubate at room temperature for 5 minutes, to permit the complete 
dissociation of the nucleoprotein complex 
 Add 200 µl of Chloroform  
 Vortex vigorously for 15 seconds 
 Incubate 3 minutes at room temperature on the bench 
 Centrifuge the sample at 12,000 x g for 15 minutes at 4°C 
 Transfer the aqueous phase of the sample (~500 µl) in a new tube 
 Keep the organic phase in the fume hood for later protein extraction 
 Add 500 µl (1 volume) of 100% isopropanol  
 Incubate at room temperature for 10 minutes 
 Centrifuge at 12,000 × g for 10 minutes at 4°C 
 Remove the supernatant from the tube, leaving only the RNA pellet 
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 Wash the pellet with 1 mL of 75% ethanol 
 Vortex the sample briefly, then centrifuge the tube at 7500 × g for 5 
minutes at 4°C and discard the wash 
 Air dry the RNA pellet for 2-3 minutes 
 Resuspend in 100 µl RNase-free water 
At this point, samples can either be stored at -80°C or purified for any non-
RNA carryover with RNeasy ® Mini Kit (Qiagen). RNA Cleanup followed the 
manufacturer protocol, briefly: 
 Add 350 µl Buffer RLT to the sample and mix well 
 Add 250 µl ethanol 100% to the diluted RNA and mix well by 
pipetting: avoid vortexing 
 Transfer the sample (700 µl) to a RNeasy Mini spin column. Spin for 
15 seconds at 13,000 rpm and discard the flow-through 
 Add 500 µl Buffer RPE to the RNeasy spin column. Let the column sit 
on the bench 5 minutes, then spin for 15 seconds 13,000 rpm and 
discard the flow-through 
 Again, add 500 µl Buffer RPE to the RNeasy spin column. Let the 
column sit on the bench 5 minutes, then spin for 2 minutes at 13,000 
rpm and throw away the 2 ml tube 
 Place the RNeasy spin column in a new 1.5 ml eppendorf tube. 
 Add 50 µl RNase-free water directly to the spin column membrane. 
Let the column sit on the bench 5 minutes, then spin for 2 minutes at 
13,000 rpm. 
 Repeat the elution of RNA with 50 µl RNase-free water in the same 
collection tube 
Purified RNAs were then quantified with Nano-Drop spectro-photometer 
(Thermo Scientific) for micro-samples and stored at -80°C. 
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Spike production 
A spike for RNA quantification was prepared digesting plasmid pLKO.1-Puro 
(Addgene plasmid 8453) with KpnI (Promega) as follows: 
pLKO.1-Puro linearization reaction 
sterile, deionized water  15.3 µl 
Optimal buffer – J – 10X 2 µl 
Acetylated BSA, 10 µg/µl 0.2 µl 
DNA (pLKO.1), 1 µg/µl 2 µl 
Restriction Enzyme Kpn I, 10 U/µl 0.5 µl 
 
Incubate for 3 hours at 37°C. 
 The linearized plasmids were purified with AMPure XP (Agencourt) magnetic 
beads: 
 Add 36 µl of beads and mix well 
 Let the beads bind to DNA leaving the tube on bench for 5 minutes 
 Transfer the tube to a magnetic separator and wait until clear 
 Aspire surnatant and wash the beads twice with 500 µl ethanol 70% 
 Spin the beads briefly, transfer the tube again on the magnetic 
separator and aspirate the remaining traces of ethanol 70% 
 Air dry for 1-2 minutes 
 Add 16 µl Nuclease-free H2O, mix well and incubate on bench for 5 
minutes 
 Put the tube on magnetic separator and transfer the solution, once 
clear, in a new tube 
Finally a transcription reaction was setup with T7 RiboMAX ™ Express RNAi 
System as follows: 
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DNA + water 16 µl 
RiboMAX 2X buffer 20 µl 
Enzyme mix 4 µl 
The reaction containing tube was incubated overnight at 37°C. 
The following day, 1 µl of DNase (supplied with the kit) was added to the 
reaction and incubated at 37°C for 30 minutes, in order to digest the original 
DNA template. An isopropanol precipitation was carried over and the RNA 
spike purified and resuspended in 100 µl of Nuclease-free water. Finally the 
RNA was quantified with Nano-Drop spectrophotometer and an aliquot was 
run on 1.5% agarose gel. 
 
Ribosomal RNA quantification 
The purified total RNA was brought to a concentration of 250 ng/µl in water 
and run in a RNA nano chip with Bioanalyzer 2100 (Agilent). The resulting 
electropherograms were exported as raw lists of time and signal and the area 
underlying the ribosomal peaks (18S and 28S) was integrated. Next the 
experiment was repeated for the same samples with the addiction of the 
generated RNA spike (50 ng/µl final) and once again the area underlying the 
peaks (ribosome subunits and the spike) was integrated. Finally the ribosomal 
RNA content was normalized to the content of the spike and compared to the 
direct measure operated previously. 
 
mRNA extraction 
The mRNA extraction was carried out with the Dynabeads mRNA DIRECT kit 
(Invitrogen) according to the manufacturer‘s protocol with some adjustments. 
A total of 25 bodies or 25 heads was processed for an expected yield of, 
respectively, 250-350 ng and 25-50 ng of mRNA. It is very important to keep 
everything cold and work quickly because of the intrinsic fragility of the 
mRNAs. Because of this, no more than six samples were processed at a time. 
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 Homogenize tissue in 500μl Lysis/Binding buffer, using 2ml ground 
glass homogenizer 
 Extract lysate from the homogenizer with a pipette and place on ice 
 Spin at 13,400 rpm for 3 minutes at 4°C and transfer surnatant to a 
new 1.5 ml tube 
 During centrifugation – take 100 µl beads into a eppendorf tube, 
place on a magnetic stand and remove buffer once clear. Wash with 
Lysis/Binding Buffer 
 Pass lysate 5 times through a 21g needle, using a 1 ml syringe, to shear 
DNA  
 Remove buffer from beads and add lysate 
 Incubate on a tube rotator at room temperature for 5 minutes 
 Capture beads for 2 minutes on the magnetic stand 
 Wash beads twice in 200 µl Wash Buffer A (supplied with the kit) 
 Wash beads twice in 200 µl Wash Buffer B (supplied with the kit) 
 Spin briefly at low speed, transfer on magnetic stand and suck out any 
lasting drop 
 Resuspend in 20 µl Tris-HCl elution buffer and place at 65 °C for 2 
minutes  
 Capture beads on magnet immediately, transfer mRNA containing 
supernatant in a new tube and put on ice 
The extraction was repeated so to cut down on rRNA contamination, re-
using the same beads. Before proceeding to the second extraction, beads 
were washed twice in Wash Buffer B. Dilute the eluted mRNA five times in 
Lysis/Binding Buffer (100 µl final), and repeat the procedure. Elute again 
the mRNA in 20 µl Tris-HCl, quantify and store at -80 °C 
 
RT-PCR 
The reverse transcription (RT) and polymerase chain reaction (PCR) 
amplification was performed with the TaqMan Reverse Transcription 
Reagents (Invitrogen): based on a MultiScribe® Reverse Transcriptase, a 
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recombinant Moloney Murine Leukemia Virus Reverse Transcriptase, and the 
combination of random hexamers and oligo (dT)16 , the kit allows the 
possibility to target either total RNA or mRNA. 
The amount of RNA used for each reaction was constant: 1.5 µg when starting 
from total RNA and 50 ng for mRNA. 
RT reaction  
Buffer 10X 5 µl 
MgCl2 11 µl 
dNTPs 10 µl 
oligo (dT)16  1.25 µl 
Random hexamers 1.25 µl 
RNase Inhibitors 1 µl 
MultiScribe® RTase 1.25 µl 
RNA + H2O to 50 µl 
 
The reverse transcription thermal cycling was always the same: 10 minutes at 
25 °C, 30 minutes at 48°C, inactivation with 5 minutes at 95 °C then hold at 4 
°C. After thermal cycling, all cDNA samples were stored at -20 °C. 
 
qPCR – targets 
Five more target genes beyond the previously described were included in the 
qPCR detection 
Gene 
Symbol 
CG 
number 
Flybase link 
Nop60B CG3333 http://flybase.org/reports/FBgn0259937.html  
PPAN CG5786 http://flybase.org/reports/FBgn0010770.html  
Act5C CG4027 http://flybase.org/reports/FBgn0000042.html  
4E-BP CG8846 http://flybase.org/reports/FBgn0261560.html  
eIF4E CG4035 http://flybase.org/reports/FBgn0015218.html 
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qPCR - primers 
All primers were designed with Primer Express Software Version 3.0 (Applied 
Biosystems) 
Gene 
Symbol 
forward primer reverse primer 
Dm CAGTTCCAGTTCGCAGTCAA TTGACTCCCGGCAGATAAAC 
RpS3 CATTGAGTTGTACGCCGAGA CTCCGGTGAGCTTGTACCTC 
RpLP0 AGGCGACACTGCTCAACATG GGAGTCGTAGACCTGGTTGACA 
RpLP2 CAGCTCTGTGGGCGTTGAG ATCAGGTCGTCGATGCTCTTG 
Qm GTGGGGATTCACCAAATACG CTCTGGGCGGTATTTCACAT 
Nop60B TCGTCATTTGCACCACCAA GCCATAGTGGCTGTGGTCATG 
PPAN CGAGGAACCAGACGAAGAACTG TTCCGCCGCCCAAACTA 
Act5C CGTGAGAAGATGACCCAGATCA AGCCTGGATGGCCACATACA 
4E-BP CGAGCGGGCTTTCATGAA CGTTGGACGGCGGAGTT 
S6k AGACCATTCTGAAAGCCAAGCT CAGGCGACGCACCAGATC 
Mnt ATTGGCGGCGTGATCTATG GCTCCACATGCCGAGGAT 
eIF4E CCCGCCGAGGCTAAGG CAGTGTTGCCTGCTGGTTCA 
 
Primers for qPCR were resuspended in TE pH 8.0 with a stock concentration 
of 110 µM. Working aliquots were made out of a ten fold dilution in H2O (11 
µM final) and stored at -20 °C. 
 
qPCR – reactions 
All the qPCR reactions were carried on MicroAmp® Optical 96-Well reaction 
plates (Applied Biosystems), with SYBR Green PCR Master Mix® (Applied 
Biosystems) in a ABI PRISM® 7900HT (Applied Biosystems) Sequence 
Detection System. 
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qPCR reaction mix  
SYBR Green mix 2x 10 µl 
Primers 1 µl 
cDNA 1 µl 
H2O 8 µl 
 
Polysome gradient – Stock solutions 
This technique relies on the absence of RNase throughout the all process; 
therefore the use of clean glass bottles and sterile equipment during the 
preparation of the stock solutions has a crucial role. Moreover all the 
solutions have been filter-sterilized before being stored at 4 °C. 
10X Polysome Salts Stock  
Tris-HCl [pH 7.4] 150 mM 
MgCl2 100 mM 
KCl 2.0 M 
ddH2O To 500 ml 
 
55% Sucrose Stock  
Sucrose 550 g 
10X Polysome Salts Stock 100 ml 
ddH2O To 1000 ml 
 
 
10% Sucrose Stock  
Sucrose 55% 91 ml 
10X Polysome Salts Stock 41 ml 
KCl 3.0 M 16.67 ml 
ddH2O To 4ml 
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45% Sucrose Stock  
Sucrose 55% 245 ml 
10X Polysome Salts Stock 5.46 ml 
KCl 3.0 M 10 ml 
ddH2O To 297 ml 
 
Lysis Buffer  
Tris-HCl [pH 7.4] 15 mM 
MgCl2 15 mM 
KCl 350 mM 
Triton X-100 1 % 
RNase Inhibitor 40U/ml 
ddH2O To 297 ml 
 
Gradient Buffer  
Tris-HCl [pH 7.4] 15 mM 
MgCl2 15 mM 
KCl 300 mM 
 
A 10 mg/ml stock solution of cycloheximide in PBS was prepared on the day 
of use and diluted 1:100 in the following solutions: 
 Cell culture media 
 Lysis buffer 
 PBS wash buffer 
 10% sucrose 
 45% sucrose 
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Polysome gradients - protocol 
The experimental protocol was kindly supplied by Mike Bronson, PhD and 
later described in literature (Bronson et al., 2010).  
 Mark the half volume line in a 15ml polyallomer tube (Beckman) 
 Pipette ~7 ml of 10% sucrose, then with a cannula carefully underlay it 
with 45% sucrose to the marked half volume line  
 Prepare a continuous 10-45% linear sucrose gradient with a Gradient 
Master (BioComp Instruments) and cool them at 4°C 
 Wash the plates to harvest twice with ice-cold PBS (added with 
cycloheximide), dry well and quickly 
 Add 200 µl lysis buffer to each plate and scrape down cells 
 Transfer in a 1.5 ml tube 
 Place the tube onto a tube rotator for 10 minutes 
 Pass lysate 5 times through a 26g needle, using a 1 ml syringe, to break 
nuclei 
 Pellet nuclei by spinning at 13,400 rpm for 12 minutes at 4°C and 
transfer surnatant into a new tube 
 Determine the OD260 and ABS 260/280 ratio of the extract by adding 
2 µl of extract to 198 µl ddH2O with a spectrophotometer 
measurement 
 Add dropwise the lysate to the gradients, adjusting paired samples for 
measured OD 
 Ultra-centrifuge in a SW40 Ti rotor (Beckman Coulter) for 3 hours at 
36,000 rpm at 4°C 
 Carefully remove the tubes from the rotor and proceed with the 
analysis 
 Polysome profiles were collected with a gradient fractionator 
(Brandel) and determined by monitoring RNA absorbance at 254 nm: 
the UV monitor sensitivity level was finally adjusted according to the 
loaded ODs 
  
 
52 
52 De Cecco M. 
Results 
Cell culture – RNAi treatment 
To quickly assess the efficiency of RNAi silencing on S2 cells a 7-days 
experiment was carried over using dsRNAs for Rho1and dm, beyond Not 
Treated (NT) cells. Inhibition of Rho1 using RNAi produces a clearly 
recognizable change in S2 cells. (Fig 6 and 7) S2 cells were treated with 
control (SK) dsRNA for 7d and photographed through phase-contrast 
microscopy. Cells are typically 5–10 mm in diameter. (Fig 7) In contrast, cells 
treated with dsRNA to deplete Rho1 for the same amount of time fail to 
complete cytokinesis and increase twofold to fourfold in diameter. 
 
  
Figure 8: Not Treated S2 cells after 2 days (on the left) and 7 days (on the right) 
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Figure 9: Rho1 S2 cells after 2 days (on the left) and 7 days (on the right) 
 
At the end of the seventh day of treatment, a 1:1 dilution of cells was counted 
and measured in viability and diameter with a Countess Automated Cell 
Counter ® (Invitrogen) 
 
Figure 10: preliminary RNAi treatment 
 
0.00E+00
2.50E+05
5.00E+05
7.50E+05
1.00E+06
dm Rho1 NT
Total cells Viable cells
  
 
54 
54 De Cecco M. 
The difference in size is statistically different among all the samples after a t 
test: Rho1 cells are bigger than the other (p < 0.01) and dm cells are smaller 
than not treated ones (p < 0.05)  
 
Average diameter (mm) Standard Dev 
Rho1 27.99 1.5 
NT 9.80 0.23 
dm 9.29 0.22 
 
Then the experiment was extended to all the produced dsRNA: dm, Qm, 
RpLp0, RpLp2 and RpS3. After 48 hours and 144 hours of treatment the cells 
were counted and measured in viability. 
 
Figure 11: total cells 
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Figure 12: viable cells 
 
Depending on the dsRNA in use the cell proliferation might be dramatically 
affected: it is the case of Qm and RpLp0, they both show a difference of nearly 
50% in cell abundance between their vector (1) and (2) (Fig 2-3). The rest of 
the genes (dm and RpS3) showed no difference at all as resulting effect of the 
two variants of dsRNA.  
Interestingly, the toxicity of dsRNA does correlate in a symmetrical way with 
the proliferation data (Fig 4): a sharp difference is present in RpS3 where the 
mortality almost doubled between the two variants, as the same stands for 
dm. 
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Figure 13: dead cells 
 
At the end of the 7-days treatment cells were either processed for RNA 
extraction or translational analysis via polysome gradients.  
 
qPCR – S2 cells 
The cDNA produced after the RNAi treatment from the S2 cells was first 
investigated for effective reduction in the target transcript. 
Both dm(1) and dm(2) strongly affected the presence of the target transcripts 
for an overall decrease of almost 75%. 
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The decrease in Qm mRNA was less significant than in the dm case, moreover 
no difference was observed between the variant (1) and (2). The RNAi 
treatment ended up in a decrease of 25% of the constitutive presence of the 
transcript. 
 
As anticipated in the preliminary observations of the RNAi effects on cell 
proliferation, the decrease of RpLp0 was quite asymmetric. The construct (1) 
actually decreased the presence of its endogenous target by ~75% while the 
variant (2) only by the 30%. 
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RpLp0 was treated with only one variant of dsRNA, that proved to be mildly 
effective bringing a reduction of the endogenous transcript of 40%. 
 
Finally, the qPCR on RpLpS3 highlighted a bold difference between variants: 
as matter of fact, RpLpS3 (2) reduced the presence of its target by 25% 
whereas RpLpS3 (1) dramatically dropped by 76%. 
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Subsequent to the analysis of the target presence, cDNA from S2 cells treated 
for seven days with dm(1) dsRNA was investigated for 5 genes and their 
putative connection to dm KD.  
Further than the 75% decrease in the dm mRNA, it resulted clear how both 
Nop60 and ppan  were drastically diminished by respectively 70 and 50% (Fig 
12). 
 
Figure 14: qPCR of related genes 
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On the contrary, three genes ended up being not affected at all: it is the case of 
eIF4E, 4Ebp and Act5. 
qPCR – flies 
To test the effect of reduced Myc expression on lifespan Professor Stephen 
Helfand (Helfand Lab, Brown University) has obtained two male Myc (dm (1) 
and dm (2)) RNAi stocks developed from the Transgenic RNAi Project (TRiP) 
at Harvard University, specifically stocks BL25783 and BL25784. The Helfand 
lab then proceeded mating the two TRiP stocks with females from a panel of 
stocks containing respectively the following GeneSwitch GAL4 drivers: 
tubulin (a ubiquitous driver, TB), Elav (a pan-neuronal driver, ES), S32 (a 
head fat body driver), and S106 (an abdominal fat body driver). This 
generated 8 stocks in which it is possible to conditionally knock-down Myc 
(dm) expression in adult flies by adding RU-486 to their food. The fruit flies 
were treated with RU-486 for 4 to 6 days and finally sent me for mRNA 
extraction, reverse transcription and qPCR, as described previously. 
With the aim of validate the most efficient driver for dm silencing several 
qPCR were done. The cDNA were made out from direct mRNA extraction 
from either 30 heads or bodies, starting from males. 
Cross Tissue Conc. mRNA (ng/µl) 
dm (1) x ES (c) Heads 6.2 
dm (1) x ES (RU) Heads 6.6 
dm (1) x ESD2 (c) Heads 8.0 
dm (1) x ESD2 (RU) Heads 11.6 
dm (1) x S32 (c) Heads 6.8 
dm (1) x S32 (RU) Heads 7.2 
dm (2) x ES (c) Heads 9.9 
dm (2) x ES (RU) Heads 8.2 
dm (2) x ESD2 (c) Heads 6.2 
dm (2) x ESD2 (RU) Heads 9.0 
dm (2) x S32 (c) Heads 10.7 
dm (2) x S32 (RU) Heads 8.4 
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Cross Tissue Conc. mRNA (ng/µl) 
dm (1) x TB (c) Bodies 45.9 
dm (1) x TB (RU) Bodies 48.2 
dm (1) x TBD2 (c) Bodies 36.4 
dm (1) x TBD2 (RU) Bodies 37.1 
dm (1) x S106 (c) Bodies 36.7 
dm (1) x S106(RU) Bodies 47.1 
dm (2) x TB (c) Bodies 36.0 
dm (2) x TB (RU) Bodies 34.3 
dm (2) x TBD2 (c) Bodies 50.4 
dm (2) x TBD2 (RU) Bodies 39.1 
dm (2) x S106 (c) Bodies 43.9 
dm (2) x S106 (RU) Bodies 40.4 
 
The qPCR reactions on the head identified a driver that decreased by 95% the 
expression of dm (myc) in the fruit flies head: it is the case of dm (1) crossed 
with S32. Interestingly, the same driver with a different variant as of dm (2) 
had the very opposite effect, enhancing the expression of the gene by almost 
250%. 
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Next, the qPCR didn‘t show any highly effective driver throughout the whole 
male body. On the other hand, dm (1) crossed with a Tubulin driver decreased 
the endogenous presence of the dm transcript by 40%. 
 
After the identification of an optimal driver of dm silencing in male fruit flies 
the experiment has been repeated with females. Interestingly no candidate 
drivers were found in the heads and neither in the whole bodies. 
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As next step, the Helfand lab bred some more stocks from TRiP with the same 
drivers. The new stocks tagged along the very same genes used in the cell 
culture: Qm (BL29356), RpLp0 (JF01335), RpLp2 (JF01516) and RpS3 
(JF01410). Males and females were both treated with RU486 and then 
processed as in the previous experiment. Only in the case of Qm it wasn‘t 
possible to test both heads and bodies, but just the heads because of 
unexpected loss of all the fruit flies carrying that genotype. 
No efficient silencing was detected either in male heads or bodies, with isolate 
exceptions of Qm with the Elav driver in the heads and partially RpLp2 
crossed with Tubulin driver. 
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The analysis run on the females, on the other hand, showed no particularly 
interesting results in the heads, where just Qm crossed with S32 had decrease 
of at least 50% of the endogenous transcript. The bodies had a better response 
to silencing in general but only few highly efficient settings were found: it is 
the case of RpLp0 and RpS3 crossed with Tubulin D2 driver; in these two 
cases , the level of target mRNA decreased of almost 50%. 
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Ribosomal RNA quantification 
Total RNA from S2 cells treated was loaded into a RNA nano chip, in a 
Bioanalyzer 2100 (Agilent). The quality score, represented as RNA Integrity 
Number (RIN) (Schroeder et al., 2006), (Imbeaud et al., 2005) had to be 
equal or higher than nine to allow the sample to be further analyzed (Fig. 6). 
 
 
 
Figure 15: RIN 
 
A total of 5 samples for group, each with its own technical replicate, were 
considered for the analysis of the ribosomal RNA content. Moreover each 
sample was evaluated in its gel-like view in order to become aware of eventual 
anomalies (Fig. 7). 
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Figure 16: gel-like view of RNA 
 
 
 Then the electropherograms data were exported as raw data and integration 
of the peaks of ribosomal RNA scored (Fig. 15-16). 
A statistically significant difference was found in the total content of 
ribosomal RNA between the Not Treated S2 cells and the dm (1) treated. The 
RNAi interference on dm has a negative effect on the cellular ribogenesis for 
an overall result of a 15% less rRNA compared to the wild type (70% versus 
85%, p value < 0.01) 
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Figure 17: representative NT electropherograms 
 
Figure 18: representative dm-treated electropherograms 
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Polysome Gradient 
First step was to get confident enough with the technique to have results 
comparable to the ones usually described in literature. To do this several 
experiment were carried over with Not Treated S2 cells, until the polysome 
gradient profile recorded at the fractionator was good enough to be used for 
quantitative comparisons.  
 
Figure 19: representative gradient profile, in the small box: gradient profile according to 
literature (courtesy of Springer Images) 
 
Finally, when the technique was reproducible enough, the final experiment 
consisted in the comparison between the profile of Not Treated S2 cells with 
dm(1) – treated cells. Each sample had both a technical replica and biological 
replica. 
80 S 
polysomes 
mRNP 
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Figure 20: Figure 7: representative gradient profile from Not Treated S2 cells (on the 
left) and from dm-treated S2 cells (on the right) 
 
It resulted evident how the silencing of dm reduced remarkably the total of 
available ribosomes, represented by the area underlying the graph. At the 
same time it shows how despite the diminished units, the dm – treated cells 
cope with the stress using a much larger fraction of free ribosomes, as shown 
by the ratio between the polysomes and the 80S areas. 
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Discussion 
The aim of this study was to test whether it was possible to develop an 
efficient model of study of dm (myc) and its role in the DR longevity pathway 
(Grandison et al., 2009). It is well known that TOR regulates protein 
synthesis (Evans et al., 2010), (Stanfel et al., 2009), (Wullschleger et al., 
2006), both by controlling the expression of ribosome biogenesis (RiBi) via 
myc, and by regulating translation initiation via genes such as S6k and 4E-BP. 
Myc is also known to regulate both RiBi genes and translation initiation 
factors (TIFs) such as eIF4E, eIF2α, eIF4AI and eIF4GI. Additionally myc 
controls transcription of many other genes involved in functions such as cell 
division, differentiation and cell death, which could in principle have a role in 
determining lifespan. In the recent years Myc‘s central role in the regulation 
of protein synthesis has emerged (van Riggelen et al., 2010). Myc has been 
shown to regulate protein synthesis at multiple levels by controlling the 
transcription of ribosomal RNA and proteins, gene involved in processing of 
ribosomal RNA, genes involved in the nuclear export of ribosomal subunits, 
and translation initiation factors. 
Both the models in vitro and in vivo proved to be effective in creating the 
optimal experimental conditions for further analysis in defining the role of 
each ribosomal protein in the network of interaction with dm (myc). 
The production via PCR and T7 RNA polymerase of large quantities of dsRNA 
proved to be efficient and cost effective. The remarkable expansion in cell 
diameter in the Rho1 – treated S2 cells was the first positive feedback of the 
experimental protocol. Additionally we checked for any effect of the dm 
dsRNA treatment on the cell‘s phenotype, detecting a small but statistically 
significant decrease in average cell diameter (5%, p value <0.19). This is 
consistent with the growth inhibition induced by Myc knock-down (van 
Riggelen et al., 2010), (Teleman et al., 2008). 
An unexpected point of interest is the asymmetrical correlation between cell 
proliferation and efficiency in gene silencing in different targets: as for 
RpLpS3, where there is a difference in cytotoxicity and proliferation rate 
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where RpLpS3 (2) is twice as lethal than the other, and when it comes to 
silencing the dsRNA variant RpLpS3 (1) proves to be three times more 
effective than RpLpS3 (2). Quite different is the case of RpLp2 where the 
transcript RpLp2 (1) has better silencing efficacy but is not linked to a higher 
cytotoxicity than its counterpart RpLp2 (2). Finally there‘s the case of dm 
(myc) where no difference in cell proliferation and mortality corresponds to a 
very similar level of silencing of the endogenous transcript. 
 Mortality rate Decrease of transcript 
RpLpS3 (1) 5.1 % 77.2% 
RpLpS3 (2) 9.4 % 25.9% 
   
RpLp0 (1) 6.1% 73.5% 
RpLp0 (2) 5.7% 31.9% 
   
dm (1) 3.8 % 70.6% 
dm (2) 2.8 % 75.8% 
 
The robustness of the experimental model in vitro has been proved by the 
qPCR data on specific targets: in dm-treated S2 cells there is a very good 
agreement between dm (myc) and its target that have been investigated. It is 
the case of Nop60 and ppan: both are known myc targets in Drosophila m. S2 
cells and show a statistically significant decrease in their endogenous 
transcript (p < 0.01).  
On the other hand, Act5 is known not to be a myc target and the quantitative 
data on its abundance are evidence for no change at all between dm-treated 
cells and Not Treated. 
Finally the two candidate genes that were investigated for dm-related 
rearrangements in expression proved no relevant differences: 4Ebp has a 
slight increase compared to the NT cells (~4%) well above any threshold of 
significance. Likewise eIF4E has small decrease (~9%) but doesn‘t pass any t-
test and therefore cannot be considered as relevant, as a matter of fact this 
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result might be of interest because eIF4E, despite its lacking the canonical e-
box on promoter region, is known to be a myc target in human but nothing is 
known about fruit-flies . 
  
Teleman et al. have demonstrated that a solid link exist between the TOR 
pathway and Myc. Specifically they showed that in D. melanogaster TORC1 
appears to regulate Myc primarily at post-transcriptional level, and that in 
vivo Myc  acts as a mediator of nutrient-regulated gene expression 
downstream of TOR. Because the vast majority of these genes are involved in 
ribosome assembly, they propose a model in which Myc mediates TOR‘s 
regulation on biogenesis. 
In this context becomes very important the fulfillment of one of the aims in 
this project, which is the identification of optimal drivers for the silencing of 
fruit-flies dm in vivo. As a matter of fact the Tubulin (ubiquitous) driver from 
TRiP stocks reduced Myc expression by ~40% after four to six days of 
treatment with RU486 in male fruit flies. Even better it‘s the behavior of the 
S32, a head fat body driver that dramatically dropped Myc expression by 95% 
with respect to controls. Hence, it is already possible to investigate the effects 
of Myc knockdown in both adult male and female fruit flies and in at least one 
tissue (head fat body). In addition, these results open the path for further 
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research on more tissue specific drivers, and also determine the amount of 
RU486 for optimal Myc knockdown. 
Furthermore we measured the level of ribosomal RNA in both Myc 
knockdown cells and Not Treated S2 cells via Bioanalyzer. The results showed 
the typical Drosophila melanogaster RNA profile, highlighting the 
statistically significant difference in ribosome abundance (~15%) between the 
two conditions, with Myc depletion leading to a much lower number of 
ribosome at a cellular level. 
To better understand how ribosome depletion translated into changes in 
protein synthesis, it was measured the fractionation profile from 10-45% 
sucrose gradients from S2 cells dm-treated and controls as described by 
Bronson et al. (Bronson et al., 2010), sucrose density gradients separated the 
ribosomes into the subpolysomal / monosome and polysome fractions. 
  
The ratio of polysomes to monosomes was relatively low, as previously 
reported in literature in normal S2 cells (Patel et al., 2009). The lower levels 
in the polysome profiles in Myc knockdown cells confirmed the overall 
ribosomal biogenesis inhibition detected with Bioanalyzer. However, while 
the overall level of ribosomes decreased, there were relatively more polysomes 
than monosomes in Myc knockdown than in controls, indicative of an 
increase of ribosomes‘ translational efficiency in Myc depleted cells. 
This is very interesting and opens the door to different possible interpretation 
as a compensatory mechanism that tries to counter the reduced availability of 
ribosomes by boosting translational efficiency of some or all mRNAs. 
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Conclusion 
The relatively large amount of work done on this project has to be considered 
only the first step since it has been considered as the preliminary result in a 5-
year grant submission to the National Institute of Health. 
Considering the experimental aims of the research, all collected data allow to 
draw some interesting conclusions. Both the in vitro and in vivo approaches 
showed their flexibility and effectiveness: large production of dsRNA via PCR 
or crossings among TRiP stocks are relatively easy to handle and optimize. 
Moreover they allow working on very large amount of subjects in very cost-
effective way. 
A consistent decrease of 75% of endogenous transcript in cells treated with 
dm – dsRNA is the optimal environment for further analysis in myc‘s control 
of protein synthesis, as our results with polysome gradients clearly show. 
Moreover the identification of highly efficient drivers throughout either the 
whole body, like Tubulin, or in a tissue specific way, like S32 allows to 
investigate the effect of Myc knockdown in adult flies. 
These results are the fundamental basis for further goals of the project, like as 
identify the Myc targets within the protein pathway that modulate lifespan 
using a combination of ChIP-seq and RNA-seq. A second crucial goal will be 
to identify what translational changes occur when lifespan is extended by 
inhibiting Myc activity, using the knowledge of the previous aim and 
combining it to measurement of translation rates via 35S method and 
polysome gradients.  
With these considerations, the 5-year grant will allow to gather critical data 
on Myc‘s control of protein synthesis via regulation of ribosomal biogenesis 
and translation initiation factors, and its effect on longevity. 
  
 
76 
76 De Cecco M. 
Bibliography 
1. Bronson MW, Hillenmeyer S, Park RW, Brodsky AS. Estrogen 
coordinates translation and transcription, revealing a role for 
NRSF in human breast cancer cells. Mol Endocrinol. 2010 
Jun;24(6):1120-35. Epub 2010 Apr 14. 
2. Chen C, Liu Y, Zheng P. mTOR regulation and therapeutic 
rejuvenation of aging hematopoietic stem cells. Sci Signal. 
2009;2(98):ra75. 
3. Dang CV, O'Donnell KA, Zeller KI, Nguyen T, Osthus RC, Li F. The 
c-Myc target gene network. Semin Cancer Biol. 2006;16(4):253-
64. 
4. Echeverri, C.J. & Perrimon, N. High-throughput RNAi screening in 
cultured cells: a user‘s guide. Nat. Rev. Genet. 7, 373–384 (2006). 
5. Elbashir, S.M. et al. Duplexes of 21-nucleotide RNAs mediate RNA 
interference in cultured mammalian cells. Nature 411, 494–498 
(2001).1,2. 
6. Estep PW, Warner JB, Bulyk ML. Short-term calorie restriction in 
male mice feminizes gene expression and alters key regulators of 
conserved aging regulatory pathways. PLoS One. 2009;4(4):e5242. 
PMCID: 2667255. 
7. Evans DS, Kapahi P, Hsueh WC, Kockel L. TOR signaling never 
gets old: Aging, longevity and TORC1 activity. Ageing Res Rev. 
2010. 
8. Fire, A. et al. Potent and specific genetic interference by double-
stranded RNA in Caenorhabditis elegans. Nature 391, 806–811 
(1998). 
9. Grandison RC, Piper MD, Partridge L. Amino-acid imbalance 
explains extension of lifespan by dietary restriction in Drosophila. 
Nature. 2009;462(7276):1061-4. PMCID: 2798000. 
10. Grandori C, Cowley SM, James LP, Eisenman RN. The 
Myc/Max/Mad network and the transcriptional control of cell 
behavior. Annu Rev Cell Dev Biol. 2000;16:653-99. 
  
 
77 
77 Part 2 – Silencing myc through RNA interference 
11. Hansen M, Chandra A, Mitic LL, Onken B, Driscoll M, Kenyon C. A 
role for autophagy in the extension of lifespan by dietary 
restriction in C. elegans. PLoS Genet. 2008;4(2):e24. PMCID: 
2242811. 
12. Hansen M, Taubert S, Crawford D, Libina N, Lee SJ, Kenyon C. 
Lifespan extension by conditions that inhibit translation in 
Caenorhabditis elegans. Aging Cell. 2007;6(1):95-110. 
13. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, 
et al. Rapamycin fed late in life extends lifespan in genetically 
heterogeneous mice. Nature. 2009;460(7253):392-5. PMCID: 
2786175. 
14. Horn T, Arziman Z, Berger J, Boutros M. GenomeRNAi: a 
database for cell-based RNAi phenotypes. 
http://genomernai.de/GenomeRNAi/ 
15. Imbeaud S, Graudens E, Boulanger V, Barlet X, Zaborski P, Eveno 
E, Mueller O, Schroeder A, and Auffray C. Towards 
standardization of RNA quality assessment using user-
independent classifiers of microcapillary electrophoresis traces, 
Nucl. Acids Res. 2005 33: e56. 
16. Kaeberlein M, Powers RW, 3rd, Steffen KK, Westman EA, Hu D, 
Dang N, et al. Regulation of yeast replicative life span by TOR and 
Sch9 in response to nutrients. Science. 2005;310(5751):1193-6. 
17. Kapahi P, Zid BM, Harper T, Koslover D, Sapin V, Benzer S. 
Regulation of lifespan in Drosophila by modulation of genes in the 
TOR signaling pathway. Curr Biol. 2004;14(10):885-90. PMCID: 
2754830. 
18. Lyne R, Smith R, Rutherford K, Wakeling M, Varley A, Guillier F, 
et al. FlyMine: an integrated database for Drosophila and 
Anopheles genomics. Genome Biol. 2007;8(7):R129. PMCID: 
2323218. 
19. Meyer N, Penn LZ. Reflecting on 25 years with MYC. Nat Rev 
Cancer. 2008;8(12):976-90. 
  
 
78 
78 De Cecco M. 
20. Pan KZ, Palter JE, Rogers AN, Olsen A, Chen D, Lithgow GJ, et al. 
Inhibition of mRNA translation extends lifespan in Caenorhabditis 
elegans. Aging Cell. 2007;6(1):111-9. PMCID: 2745345. 
21. Patel PH, Costa-Mattioli M, Schulze KL, Bellen HJ. The 
Drosophila deoxyhypusine hydroxylase homologue nero and its 
target eIF5A are required for cell growth and the regulation of 
autophagy. J Cell Biol. 2009;185(7):1181-94. PMCID: 2712966. 
22. Ramet, M. et al. Functional genomic analysis of phagocytosis and 
identification of a Drosophila receptor for E. coli. Nature 416, 
644–648 (2002). 
23. Rogers SL and Rogers GC. Culture of Drosophila S2 cells and their 
use for RNAi-mediated loss-of-function studies and 
immunofluorescence microscopy. Nat Protoc. 2008;3(4):606-11. 
24. Rogers SL, Wiedemann U, Stuurman N, Vale RD. Molecular 
requirements for actin-based lamella formation in Drosophila S2 
cells. J Cell Biol. 2003 Sep 15;162(6):1079-88. 
25. Schneider, I. Cell lines derived from late embryonic stages of 
Drosophila melanogaster. J. Embryol. Exp. Morphol. 27, 353–365 
(1972). 
26. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, 
Gassmann M, Lightfoot S, Menzel W, Granzow M and Ragg T. The 
RIN: an RNA integrity number for assigning integrity values to 
RNA measurements. BMC Molecular Biology 2006, 7:3 
27. Selman C, Tullet JM, Wieser D, Irvine E, Lingard SJ, Choudhury 
AI, et al. Ribosomal protein S6 kinase 1 signaling regulates 
mammalian life span. Science. 2009;326(5949):140-4. 
28. Stanfel MN, Shamieh LS, Kaeberlein M, Kennedy BK. The TOR 
pathway comes of age. Biochim Biophys Acta. 
2009;1790(10):1067-74.  
29. Steffen KK, MacKay VL, Kerr EO, Tsuchiya M, Hu D, Fox LA, et al. 
Yeast life span extension by depletion of 60s ribosomal subunits is 
mediated by Gcn4. Cell. 2008;133(2):292-302. PMCID: 2749658. 
  
 
79 
79 Part 2 – Silencing myc through RNA interference 
30. Storey JD, Tibshirani R. Statistical significance for genomewide 
studies. Proc Natl Acad Sci U S A. 2003;100(16):9440-5. PMCID: 
170937. 
31. Teleman AA, Hietakangas V, Sayadian AC, Cohen SM. Nutritional 
control of protein biosynthetic capacity by insulin via Myc in 
Drosophila. Cell Metab. 2008;7(1):21-32. 
32. van Riggelen J, Yetil A, Felsher DW. MYC as a regulator of 
ribosome biogenesis and protein synthesis. Nat Rev Cancer. 
2010;10(4):301-9. 
33. Vellai T, Takacs-Vellai K, Zhang Y, Kovacs AL, Orosz L, Muller F. 
Genetics: influence of TOR kinase on lifespan in C. elegans. 
Nature. 2003;426(6967):620. 
34. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and 
metabolism. Cell. 2006;124(3):471-84. 
35. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and 
metabolism. Cell. 2006;124(3):471-84. 
36. Zid BM, Rogers AN, Katewa SD, Vargas MA, Kolipinski MC, Lu 
TAl. 4E-BP extends lifespan upon dietary restriction by enhancing 
mitochondrial activity in Drosophila. Cell. 2009;139(1):149-60. 
PMCID: 2759400. 
  
 
81 
81 
   
 
 
Homo sapiens &  Mus musculus  
 
 
 
  
 
82 
82 De Cecco M. 
PART 3 – DEVELOPMENT OF A BIOMARKER FOR 
SENESCENCE 83 
Introduction: why stain proteins 83 
Appendix 1 – Preliminary data 86 
Defining the protocol 86 
Fluorescamine 86 
OPA (o-phthaldialdehyde) 88 
CBQCA Protein Quantitation Kit 89 
NanoOrange protein quantitation assay 90 
Staining of mouse tissues 93 
Lung 93 
Liver 95 
Kidney 96 
Remarks 97 
Appendix 2 – Published data 98 
Bibliography 101 
  
 
83 
83 Part 3 – Development of a biomarker for senescence 
Part 3 – Development of a biomarker for senescence 
Introduction: why stain proteins 
In time normal diploid cell lines as fibroblasts have been studied extensively. 
It is well known that normal somatic cells, with the exception of germ cells 
and some stem cells, display a finite replicative capacity. This phenomenon 
was first described in cultured human fibroblasts (Hayflick and Moorhead, 
1961), and is commonly referred to as replicative cellular senescence. Their 
differentiation sequence from mitotic to postmitotic fibroblasts was 
documented in chicken, mice, rats and man (Bayreuther et al., 1991), and thus 
were always considered as optimal representative models for studies of 
general or special issues of cell biology, such as aging. Cellular senescence has 
been studied predominantly in cell culture (in vitro) under a variety of 
pathological and normal conditions (Sedivy et al., 2008), (Jun et al., 2011) 
(Nardella et al., 2011). Among other features, early studies revealed that aging 
of the cells corresponded to remarkable changes in size and shape (Hayflick, 
1968), (Hayflick, 1972), (Cristofalo and Pignolo, 1993) involving an 
adjustment in cellular protein or at least an alteration of their balance inside 
the aging fibroblasts. 
Early studies aimed to measure first any changes in rates of both synthesis 
and turnover between late and early passage cells, finding that the senescent 
cells were consistently more altered thus supporting  those theories of cellular 
senescence which predict altered protein metabolism as a major consequence 
of the aging process (Dell‘orco et al., 1976). Deepening the analysis it turned 
out how not only the rate of protein synthesis is reduced in senescent cultures, 
but the average rate of protein degradation is also considerably slowed down: 
the protein content of senescent cells increases by 1.8-fold as compared to 
young cells, while the average cell volume is increased even more (almost 5-
fold). (Kraftory et al., 1978). Biochemical analysis conducted in our lab 
confirmed the increase in protein content in whole cells and compared the 
nuclear fractions of early passage and senescent cells, proving an increase of 
~3-folds. 
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Interestingly enough to our knowledge no one else has ever investigated the 
protein content on a single cell level: an important limiting factor has been 
the lack of a well developed and accepted staining method for total protein 
suitable for fluorescence microscopy. This is in contrast to DNA, where dyes 
based either on intercalation (acridine) or minor groove binding (DAPI, 
Hoechst) have been widely used for some time, and have enabled many high 
resolution as well as quantitative studies in numerous applications. While a 
number of sensitive staining methods have been developed for protein 
quantification in solution as well as on solid supports (Noble et al., 2009), 
these principles have not been extended and generalized for fluorescence 
microscopy. Therefore we decided to develop a flexible assay meant to easily 
assess the quantity of protein per cell, and in particular, inside the nucleus. 
After the screening of several fluorescent dyes with different chemistry of 
interactions with proteins like Fluorescamine, OPA and QCBCA, our attention 
was driven onto NanoOrange® (Invitrogen).  
It is a merocyanine dye that produces a large increase in fluorescence 
quantum yield upon interaction with detergent-coated proteins (Jones et al., 
2003). It stood up among others because of its wide range sensibility, its 
insensitivity to nucleic acid and, above all, for its ease of use. The aim of this 
work was to develop an assay that allows to measure single cell protein 
content via immunofluorescence. Besides we considered of extreme interest 
the possibility to couple the newly developed assay with a classical 
immunofluorescence experiment so as to have information about specific 
targets presence and relate them to a global condition of the cell. 
By doing this we showed how the extent of the total protein staining is 
maintained whilst we investigated well recognized markers as macroH2A, 
Lamin A/C and histone H3 in early passage and senescent cells.  
Furthermore we conducted the whole work on two different cell lines of 
fibroblasts as human lung and mouse tail in order to draw attention to the 
flexibility and the potential of the assay here presented. 
The point of the project was to develop a reliable assay: to this extend several 
attempts were made with different approaches, methods and dyes. At the 
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same way, not all the experiments and results are reported in the final paper: 
so a brief recap of the rest of the work done is summed in the Supplemental 
Data part. 
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Appendix 1 – Preliminary data 
Defining the protocol 
It took some time to define the best dye in order to stain cellular proteins. 
This is mainly due to the large availability of different products on the market; 
as a matter of fact they rely on different chemistries and various 
chromophores. Moreover no commercial dye has been designed to fulfill 
exactly our experimental aims: indeed they are meant to quantify protein in 
solution or in a gel, while our purpose was to quantify cells in situ on a single 
cell scale. 
During the experimental activity we started from dyes that react with primary 
amine groups on proteins, such as Fluorescamine, OPA (o-phthaldialdehyde) 
and CBQCA. Only afterwards we changed principle, using NanoOrange that 
binds to detergent coating on proteins and hydrophobic regions of proteins. 
Most of the preliminary work isn‘t mentioned in the article journal published 
at the end of the project that‘s the reason why it will be written here in form of 
Supplemental Information. 
Fluorescamine 
Fluorescamine is intrinsically nonfluorescent but reacts rapidly with primary 
aliphatic amines to yield a blue-green-fluorescent derivative with 
excitation/emission maxima ~380/464 nm. 
Molecular Formula: C17H10O4 
Molecular Weight: 278.2636 
CAS Name: Spiro(furan-2(3H),1'(3'H)-
isobenzofuran)-3,3'-dione, 4-phenyl 
 
Figure 21: Fluorescamine molecular structure 
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Despite being widely used in the past (Kagan et al., 2002),(Cesur et al., 2002), 
fluorescamine has several issues like as the pH of the buffer: when pH 
increases, excess fluorescamine is more rapidly hydrolyzed, forming a product 
that is unreactive toward amines. At low pH, protonation of amines further 
interferes with the fluorescamine derivatization reaction.  
All in all, the reagent is quite unstable and it isn‘t compatible with amine-
containing buffers (like Tris or glycine). 
Various protocols have been tested but no reproducibility nor stability has 
been detected. Cells are stained unevenly both in early passage (passage 15) 
human Lung Fibroblast cells (hLF1) and senescent cells (passage 52). 
Therefore the dye was rejected and replaced. 
  
Figure 22: representative image of Early Passage LF1 stained with fluorescamine 
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OPA (o-phthaldialdehyde) 
The aromatic dialdehyde o-phthaldialdehyde (OPA) is essentially 
nonfluorescent until reacted with a primary amine in the presence of excess 
cyanide or a thiol, to yield a fluorescent isoindole with excitation/emission 
maxima ~334/455 nm. 
Molecular Formula: C8H6O2 
Molecular Weight: 134.1342 
CAS Name: 1,2-Benzenedicarboxaldehyde 
 
Figure 23: OPA molecular structure 
 
OPA is still used very often (Go et al., 2008), (Yamamoto et al., 2008), 
(Hapuarachchi and Aspinwall, 2007), because of its fast kinetic properties, its 
ease of use and low cost. Although despite all these advantageous features, 
OPA resulted not suitable for our purposes since the signal was not stable and 
reproducible. 
 
Figure 24: representative image of Early Passage LF1 stained with OPA 
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CBQCA Protein Quantitation Kit 
The CBQCA Protein Quantitation Kit (Molecular Probes ®, cat. No. C-6667) 
is a very sensitive assay for quantitating proteins in solution, capable of 
detection as low as 10 ng of protein per mL (Graves et al., 2005), (Huang et 
al., 2006). Similar in sensitivity to another dye, NanoOrange, CBQCA is 
supposed to be better suited for accurate quantitation of proteins in the 
presence of lipids and for lipoproteins. 
Molecular Formula: C18H11NO4 
Molecular Weight: 305.2892 
CAS Name: N / A 
 
Regardless of its many features, as sensitivity and linearity,  the Atto-Tag ™ 
CBQCA derivatization reagent failed in meeting the experimental goals. No 
statistical analysis could be done on single cell level so the dye was replaced. 
 
Figure 25: representative image of Early Passage LF1 stained with Atto-Tag™ CBQCA 
 
According to our results, the reason for the failure of all the previous  dyes 
relies on the staining reaction itself: all of them are meant to work at room 
temperature in a ―pure‖ enviroment, like as protein in solution. For our 
purposes we had to adjust this since the staining of protein in situ requires a 
different level of flexibility. 
Bearing these consideration we changed approach and moved to a dye that 
binds to detergent coating on proteins and hydrophobic regions of proteins; 
moreover the staining step requires a 95°C denaturation step, differently from 
all the other tested methods. 
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NanoOrange protein quantitation assay 
The NanoOrange Protein Quantitation Kit (Molecular Probes ®, cat. No. N-
6666) contains a very sensitive and easy assay for protein quantitation, with 
detection as low as 10 ng/mL of protein in solution. During the preliminary 
experiments it resulted  perfect for our purposes, allowing a neat and constant 
detection of both cytoplasmic and nuclear proteins. 
  
Figure 26: representative image of Early Passage LF1 stained with NanoOrange® 
  
The detergent mixture used as diluent in the staining step as for the dye itself 
(a merocyanine) are both covered by patent. From the very beginning the 
assay looked promising; the analysis was then performed on a confocal 
microscope rather than a fluorescence one, so to improve image resolution 
and reduce cross-talking between dyes. The protocol required some fine 
tuning to identify the optimal working condition, all the steps are described in 
the final paper in the Supplemental Data. 
Once the optimal protocol was defined several hundreds of images were 
collected and analyzed, both for the normal human diploid fibroblast 
mentioned above (LF1) and primary adult mouse tail fibroblasts (MTF). 
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Figure 27: representative image of Early Passage LF1. On the left, DAPI counter stains 
the DNA. On the right, NanoOrange stains cellular proteins. [bar = 20µm] 
 
 
Figure 28: representative image of Senescent LF1. On the left, DAPI counter stains the 
DNA. On the right, NanoOrange stains cellular proteins. [bar = 20µm] 
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Figure 29: representative image of Early Passage MTF. On the left, DAPI counter stains 
the DNA. On the right, NanoOrange stains cellular proteins. [bar = 20µm] 
 
 
Figure 30: representative image of Senescent MTF. On the left, DAPI counter stains the 
DNA. On the right, NanoOrange stains cellular proteins. [bar = 20µm] 
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Staining of mouse tissues 
Lung 
Samples from 6 young (5 months old) and 6 old (36 months old) animals were 
embedded in OCT and cut in cryostat at Chamber Temperature -29°C and a 
Object Temperature of -27°C.  
As for all the other tissue experiments, the 7 µm slices were melted on a  poly-
lysine covered coverslip and immediately fix with 4% paraformaldehyde, 0.5% 
Triton X-100 at Room Temperature for exactly 20 minuntes. Coverslips were 
then washed three times in PBS-T 0.2% and the staining protocol was carried 
over as described in the paper. 
 
Figure 31: representative images of 5 mo mouse lung stained for total protein (green in 
the confocal's pseudocolors) and counterstained for DNA (red in confocal's 
pseudocolors). 
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Figure 32: representative images of 36 mo mouse lung stained for total protein and 
counterstained for DNA. 
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Liver 
Samples were processed in the exact same way as lung, picking 6 young and 6 
old animals. In this case the cutting temperature in the cryostat was -19°C as 
Chamber Temperature and -17°C as Object Temperature. 
 
Figure 33: representative images of 5 mo mouse liver stained for total protein (green) 
and counterstained for DNA (red). 
 
 
Figure 34: representative images of 36 mo mouse liver stained for total protein (green) 
and counterstained for DNA (red). 
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Kidney 
Samples were processed in the exact same way as liver and lung, with the 
same 6 young and 6 old animals. In this last case, the cutting temperature in 
the cryostat was -23°C as Chamber Temperature and -21°C as Object 
Temperature. 
 
Figure 35: representative images of 5 mo mouse kidney stained for total protein (green) 
and counterstained for DNA (red). 
 
 
Figure 36: representative images of 36 mo mouse kidney stained for total protein (green) 
and counterstained for DNA (red). 
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All the images obtained have been processed and quantify for nuclear protein 
content and several other feature that may become crucial in further models. 
Remarks 
Overall the data that haven‘t been published in the paper, especially the ones 
from tissues are very solid and coherent among them. They will be absolutely 
kept in high regard when planning further experiments on this newly 
developed biomarker as it is the nuclear protein content. Our knowledge in 
terms of nuclear proteins will soon be expanded with more tissues, like as 
brain, muscle and spleen; this is going to end in a better definition of the 
nuclear complexity in vivo and in a very important database of results to 
correlate with parallel specific information. 
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Appendix 2 – Published data 
 
We have developed an easy and flexible method, based on the merocyanine 
dye known as NanoOrange, to visualize and quantitatively measure total 
protein levels by high resolution fluorescence microscopy. In the paper we 
published the results of NanoOrange stainings, plus their combination with 
antibody-based immunofluorescence, thus providing both specific target and 
total protein information in the same specimen. Combining the method with 
automated image analysis platforms it was possible to run high throughput 
analysis.  
We document here increasing protein content and density in nuclei of 
senescent human and mouse fibroblasts in vitro, and in liver nuclei of aged 
mice in vivo. 
 
Article: 
Nuclear protein accumulation in cellular 
senescence and organismal aging revealed with a 
novel single-cell resolution fluorescence 
microscopy assay. 
De Cecco M, Jeyapalan J, Zhao X, Tamamori-Adachi M, Sedivy JM. 
Aging (Albany NY). 2011 Oct;3(10):955-67. 
PMID: 22006542 
URL: http://www.ncbi.nlm.nih.gov/pubmed/22006542 
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